Back to Trades
MELTZER LESLIE
InsiderCIK 0002084030
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
MELTZER LESLIE has filed 4 SEC reports (2025–2026), all concentrated in Apellis Pharmaceuticals, Inc. (APLS), totaling $4.1M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| May 14 | APLS Apellis Pharmaceuticals, Inc. | MELTZER LESLIE | Insider | Grant | $2.6M |
| Jan 30 | APLS Apellis Pharmaceuticals, Inc. | MELTZER LESLIE | Chief Research and Development | Grant | $0 |
| Sep 2 | APLS Apellis Pharmaceuticals, Inc. | MELTZER LESLIE | Chief Research and Development | Grant | $1.5M |
| Sep 2 | APLS Apellis Pharmaceuticals, Inc. | MELTZER LESLIE | Chief Research and Development | Other | $0 |
4 filings